The results showed that AML patients commonly contain a higher proportion of ALKBH5, CBLL1, FTO, HNRNPA2B1, HNRNPC, IGF2BP1, IGF2BP2, IGF2BP3, METTL14, METTL16, METTL3, RBM15, RBM15B, RBMX, KIAA1429, WTAP, YTHDC1, YTHDC2, YTHDF1, YTHDF2, YTHDF3, ZC3H13, ZNF217 (Figure 2A). This evidence concerns the gene METTL3 and acute myeloid leukemia.